Breaking
Friday, June 19, 2026

FDA News

🇺🇸 FDA Page 22

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.

Showing 253–264 of 391 articles

Medium impact AnalysisMay 23, 2026

FDA Approval for Datroway: Implications for Breast Cancer Treatment

FDA · breast cancer · 2 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 23, 2026

Five Key Regulatory Updates to Watch at ASCO

FDA · 4 min

Dr. Sarah Mitchell
Medium impact NewsMay 23, 2026

FDA Approves 17 Drugs with Continuous Manufacturing: Implications for Pharma

FDA · 2 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 23, 2026

FDA Approves First Treatment for Chronic Hepatitis Delta Virus Infection

FDA · hepatitis · 3 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 23, 2026

FDA Approves Gilead's Hepatitis D Drug: Implications for Pharma

FDA · hepatitis · 2 min

Dr. Sarah Mitchell
Medium impact NewsMay 22, 2026

FDA's Guidance on Animal Testing Alternatives: Industry Concerns

FDA · 2 min

Dr. Sarah Mitchell
Medium impact NewsMay 22, 2026

Aptar Pharma Advances FDA-Funded Research Contract for Drug Approvals

FDA · 2 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 22, 2026

First RAS Inhibitor Extends Survival in Metastatic Pancreatic Cancer

FDA · metastatic pancreatic adenocarcinoma · 3 min

Dr. Sarah Mitchell
Medium impact NewsMay 22, 2026

FDA Fast Track Designation for Oncology Drugs: April 2026 Insights

FDA · oncology · 3 min

Dr. Sarah Mitchell
Medium impact NewsMay 22, 2026

FDA in Flux: May 2026 Drug Approvals Update

FDA · 2 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 21, 2026

Covert Campaign: Biotechs vs. FDA Commissioner

FDA · 3 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 21, 2026

Whoop and FDA: Navigating Controversies in Blood Pressure Monitoring

FDA · 2 min

Dr. Sarah Mitchell